Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Non-Current Deffered Revenue (2018 - 2026)

Health Catalyst filings provide 9 years of Non-Current Deffered Revenue readings, the most recent being $227000.0 for Q1 2026.

  • On a quarterly basis, Non-Current Deffered Revenue fell 44.23% to $227000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $227000.0, a 44.23% decrease, with the full-year FY2025 number at $410000.0, up 64.66% from a year prior.
  • Non-Current Deffered Revenue hit $227000.0 in Q1 2026 for Health Catalyst, down from $410000.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $631000.0 in Q1 2022 to a low of $51000.0 in Q2 2024.
  • Median Non-Current Deffered Revenue over the past 5 years was $258000.0 (2024), compared with a mean of $274882.4.
  • Biggest five-year swings in Non-Current Deffered Revenue: plummeted 88.7% in 2022 and later skyrocketed 545.1% in 2025.
  • Health Catalyst's Non-Current Deffered Revenue stood at $105000.0 in 2022, then decreased by 26.67% to $77000.0 in 2023, then skyrocketed by 223.38% to $249000.0 in 2024, then soared by 64.66% to $410000.0 in 2025, then crashed by 44.63% to $227000.0 in 2026.
  • The last three reported values for Non-Current Deffered Revenue were $227000.0 (Q1 2026), $410000.0 (Q4 2025), and $385000.0 (Q3 2025) per Business Quant data.